Analysis of free-living daytime movement in patients with migraine with access to acute treatment

被引:0
|
作者
van der Donckt, Jonas [1 ]
Vandenbussche, Nicolas [2 ,3 ,4 ]
De Brouwer, Mathias [1 ]
Steenwinckel, Bram [1 ]
Stojchevska, Marija [1 ]
Ongenae, Femke [1 ]
Paemeleire, Koen [2 ,3 ]
Van Hoecke, Sofie [1 ]
机构
[1] Ghent Univ imec, IDLab, Technol Pk Zwijnaarde 126, B-9052 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Neurol, Corneel Heymanslaan 10, B-9000 Ghent, Belgium
[3] Univ Ghent, Fac Med & Hlth Sci, Dept Basic & Appl Med Sci, Corneel Heymanslaan 10, B-9000 Ghent, Belgium
[4] AZ Sint Jan Bruges, Dept Neurol, Ruddershove 10, B-8000 Brugge, Belgium
关键词
Migraine; Actigraphy; Wearable; Movement; Real-world; Activity recognition; Digital biomarker; PHYSICAL-ACTIVITY; HEADACHE; SENSITIZATION; CHALLENGES; POSTDROME;
D O I
10.1186/s10194-025-01971-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundMotion can exacerbate headache during a migraine attack, potentially leading to avoidance of routine physical activity. Advances in wrist-worn actigraphy facilitate objectively analyzing how headache episodes affect physical activity in everyday settings. The primary hypothesis was hypoactivity during daytime headache events. Secondary hypotheses are hypoactivity during the prodromal and postdromal hours closest to the headache event.MethodsDuring a 90-day prospective observational study, participants diagnosed with migraine wore an actigraphy device on their non-dominant wrist during daily life and work, while also logging migraine-related data in a dedicated smartphone application. There were no restrictions on use of acute and preventive headache treatments. Data from the wrist-worn accelerometer were used to (i) calculate activity energy expenditure, and (ii) predict types of human activities. These metrics were used to compare daytime prodromal, ictal, and postdromal phases of headache events with time-matched intervals during non-headache periods.ResultsA significant reduction in daytime physical activity was observed during the ictal phase of headache attacks, as evidenced by decreases in both activity energy expenditure and human activity recognition prediction metrics. A reduction in movement was also observed during evening hours (18:00-24:00) on headache days. However, no significant physical activity changes were noted in the prodromal and postdromal phases. Reduced physical activity was more pronounced during the ictal phase when acute treatments were ineffective.ConclusionsThis study is the first to examine the impact of headache on physical activity levels during daytime headache events by assessing changes in daily activities and activity energy expenditure in individuals with migraine, within their habitual environments and without restrictions on acute medication use. Our findings confirm reduced movement during the ictal phase of migraine attacks, supporting the primary hypothesis. Wrist-worn actigraphy further indicated that this reduction is more pronounced when patients experience movement sensitivity. Evening hypoactivity is also observed on headache days. Furthermore, attacks with ineffective acute treatment or moderate-to-high intensity were associated with more pronounced reductions in movement. In contrast, our data did not support the secondary hypothesis that physical activity would decrease during daytime prodromal and postdromal periods.Trial registrationNCT04983186 (www.ClinicalTrials.gov).
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial
    Jonsson, Linus
    Regnier, Stephane A.
    Kymes, Steven
    Awad, Susanne F.
    Talon, Brian
    Lee, Xin Ying
    Goadsby, Peter J.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (07) : 797 - 803
  • [32] The Efficacy and Safety of Prochlorperazine in Patients With Acute Migraine: A Systematic Review and Meta-Analysis
    Golikhatir, Iraj
    Cheraghmakani, Hamed
    Bozorgi, Farzad
    Jahanian, Fatemeh
    Sazgar, Mohammad
    Montazer, Seyed Hosein
    HEADACHE, 2019, 59 (05): : 682 - 700
  • [33] Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine
    Bonafede, Machaon
    Wilson, Kathleen
    Xue, Fei
    CEPHALALGIA, 2019, 39 (09) : 1086 - 1098
  • [34] Calcitonin gene-related peptide antagonism for acute treatment of migraine: a meta-analysis
    Hong, Peiwei
    Liu, Yao
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2017, 127 (01) : 20 - 27
  • [35] SUBCUTANEOUS SUMATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE IN PATIENTS USING DIHYDROERGOTAMINE AS PROPHYLAXIS
    HENRY, P
    DALLENS, H
    HEADACHE, 1993, 33 (08): : 432 - 435
  • [36] Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints
    Vikelis, Michail
    Rikos, Dimitrios
    Argyriou, Andreas A.
    Papachristou, Pinelopi
    Rallis, Dimitrios
    Karapanayiotides, Theodoros
    Galanopoulos, Andreas
    Spingos, Konstantinos
    Dimisianos, Nikolaos
    Giakoumakis, Emmanouil
    Zavridis, Periklis
    Notas, Konstantinos
    Vlachos, George S.
    Soldatos, Panagiotis
    Bilias, Konstantinos
    Xiromerisiou, Georgia
    Rudolf, Jobst
    Dermitzakis, Emmanouil V.
    Rapoport, Alan M.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (08) : 815 - 826
  • [37] The effect of metformin treatment on volumes of free-living physical activity and sedentary behaviour: A post-hoc analysis of the PRE-D trial
    Karstoft, Kristian
    Ried-Larsen, Mathias
    Bruhn, Lea
    Pilmark, Nanna Skytt
    Hansen, Katrine Bagge
    Persson, Frederik
    Jorgensen, Marit Eika
    Blond, Martin Baek
    Faerch, Kristine
    JOURNAL OF SPORTS SCIENCES, 2023, 41 (18) : 1687 - 1691
  • [38] Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine
    Chen, Li-Chia
    Ashcroft, Darren M.
    HEADACHE, 2008, 48 (02): : 236 - 247
  • [39] Phase 2 randomized placebo-controlled study of lasmiditan for the acute treatment of migraine in Japanese patients
    Sakai, Fumihiko
    Takeshima, Takao
    Homma, Gosuke
    Tanji, Yuka
    Katagiri, Hideaki
    Komori, Mika
    HEADACHE, 2021, 61 (05): : 755 - 765
  • [40] Validation of the StepWatch Device for Measurement of Free-Living Ambulatory Activity in Patients With Chronic Obstructive Pulmonary Disease
    Nguyen, Huong Q.
    Burr, Robert L.
    Gill, Dawn P.
    Coleman, Kim
    JOURNAL OF NURSING MEASUREMENT, 2011, 19 (02) : 76 - 90